Skip to main navigation Skip to search Skip to main content

Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG

  • A Jalili
  • , P Calzavara-Pinton
  • , L Kircik
  • , D Lons-Danic
  • , A Pink
  • , S Tyring
  • , P de la Cueva
  • , M Gooderham
  • , S Segaert
  • , N Nyholm
  • , H Thoning
  • , B Petersen
  • , D Thaçi
  • Addiction Switzerland
  • University of Brescia
  • Indiana University-Purdue University Indianapolis
  • University of Louisville
  • Fondation Hôpital Saint Joseph
  • Université de Paris
  • AstraZeneca France, Rueil Malmaison, France.
  • St John's Institute of Dermatology
  • Baylor College of Medicine
  • University Hospital Infanta Leonor de Madrid
  • Queen's University, Kingston
  • University Hospitals Leuven, Belgium.
  • LEO Pharma A/S
  • Sclerose Hospital Erne, Ry, Denmark.
12   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Medicine and Dentistry